Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alternate Dosing of PROCRIT in Chemotherapy Induced Anemia
NCT00338299Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Aug 2003
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
A Phase 2 trial of epoetin alfa, sponsored by Johnson & Johnson. Started Aug 2003; status: completed.
02
Drugs
epoetin alfa
Beyond the preview
Go deeper on NCT00338299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00338299.